MIR137 variants identified in psychiatric patients affect synaptogenesis and neuronal transmission gene sets

Molecular Psychiatry

Volumn 20, Issue 4, 2015, Pages 472-481

  Strazisar, M ^a   Cammaerts, S ^a   Van Der Ven, K ^a,h   Forero, D A ^a,b   Lenaerts, A S ^a,i   Nordin, A ^c   Almeida Souza, L ^a,d   Genovese, G ^e,f   Timmerman, V ^a,d   Liekens, A ^a   De Rijk, P ^a   Adolfsson, R ^c   Callaerts, P ^g   Del Favero, J ^a,h  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b CENTRO DE INVESTIGACIONES   (Colombia)

^c UMEÅ UNIVERSITY   (Sweden)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h KU Leuven ^*  (Belgium)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 137; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; MICROARRAY ANALYSIS; NERVOUS SYSTEM DEVELOPMENT; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; RNA ISOLATION; SEMI STRUCTURED INTERVIEW; SEQUENCE ANALYSIS; SYNAPTIC TRANSMISSION; SYNAPTOGENESIS; CHEMICAL STRUCTURE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; NEUROBLASTOMA; PATHOLOGY; SWEDEN; TUMOR CELL LINE; VARIABLE NUMBER OF TANDEM REPEAT;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE FREQUENCY; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MENTAL DISORDERS; MICROARRAY ANALYSIS; MICRORNAS; MINISATELLITE REPEATS; MODELS, MOLECULAR; NEUROBLASTOMA; NEUROGENESIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SWEDEN; SYNAPTIC TRANSMISSION; TRANSFECTION;

EID: 84926139786     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.53     Document Type: Article

References (81)

1. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
2. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
3. Mattick JS. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2001; 2: 986-991.
4. Perkins DO, Jeffries C, Sullivan P. Expanding the 'central dogma': the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia. Mol Psychiatry 2005; 10: 69-78.
5. Pillai RS. MicroRNA function: multiple mechanisms for a tiny RNA? RNA 2005; 11: 1753-1761.
6. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858.
7. Lai EC. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 2002; 30: 363-364.
8. Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci USA 2008; 105: 1608-1613.
9. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: micro- RNAs can up-regulate translation. Science 2007; 318: 1931-1934.
10. He X, Zhang Q, Liu Y, Pan X. Cloning and identification of novel microRNAs from rat hippocampus. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 708-714.
11. Bak M, Silahtaroglu A, Moller M, Christensen M, Rath MF, Skryabin B et al. MicroRNA expression in the adult mouse central nervous system. RNA 2008; 14: 432-444.
12. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007; 8: 166.
13. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-1414.
14. Beveridge NJ, Tooney PA, Carroll AP, Tran N, Cairns MJ. Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation. Cell Signal 2009; 21: 1837-1845.
15. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15: 1176-1189.
16. Xu B, Hsu PK, Karayiorgou M, Gogos JA. MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction. Neurobiol Dis 2012; 46: 291-301.
17. Beveridge NJ, Cairns MJ. MicroRNA dysregulation in schizophrenia. Neurobiol Dis 2012; 46: 263-271.
18. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
19. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet 2003; 73: 49-62.
20. Ripke S, Sanders AR, Kendler KS, Levinson DF, Sklar P, Holmans PA et al. Genomewide association study identifies five new schizophrenia loci. Nat Genet 2011; 43: 969-976.
21. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, Akterin S et al. Genomewide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013; 45: 1150-1159.
22. Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun 2005; 331: 1439-1444.
23. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA et al. SNPs in human miRNA genes affect biogenesis and function. RNA 2009; 15: 1640-1651.
24. Ma H, Wu Y, Choi JG, Wu H. Lower and upper stem-single-stranded RNA junctions together determine the Drosha cleavage site. Proc Natl Acad Sci USA 2013; 110: 20687-20692.
25. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res 2008; 18: 610-621.
26. Marti E, Pantano L, Banez-Coronel M, Llorens F, Minones-Moyano E, Porta S et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 2010; 38: 7219-7235.
27. Zhou H, Arcila ML, Li Z, Lee EJ, Henzler C, Liu J et al. Deep annotation of mouse iso-miR and iso-moR variation. Nucleic Acids Res 2012; 40: 5864-5875.
28. Neilsen CT, Goodall GJ, Bracken CP. IsomiRs-the overlooked repertoire in the dynamic microRNAome. Trends Genet 2012; 28: 544-549.
29. Kozlowska E, Krzyzosiak WJ, Koscianska E. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs. Int J Mol Sci 2013; 14: 16999-17016.
30. Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S et al. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol 2011; 12: R126.
31. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
32. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59: 97-105.
33. Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF et al. ViennaRNA Package 2.0. Algorithms Mol Biol 2011; 6: 26.
34. Darty K, Denise A, Ponty Y. VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics 2009; 25: 1974-1975.
35. Almeida-Souza L, Goethals S, de Winter V, Dierick I, Gallardo R, Van Durme J et al. Increased monomerization of mutant HSPB1 leads to protein hyperactivity in Charcot-Marie-Tooth neuropathy. J Biol Chem 2010; 285: 12778-12786.
36. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
37. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 2007; 8: R19.
38. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121.
39. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, Howe EA et al. TM4 microarray software suite. Methods Enzymol 2006; 411: 134-193.
40. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34: 267-273.
41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
42. Green MJ, Cairns MJ, Wu J, Dragovic M, Jablensky A, Tooney PA et al. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol Psychiatry 2013; 18: 774-780.
43. Lett T, Chakavarty M, Felsky D, Brandl E, Tiwari A, Gon?alves V et al. The genomewide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia. Mol Psychiatry 2013; 18: 443-450.
44. Whalley HC, Papmeyer M, Romaniuk L, Sprooten E, Johnstone EC, Hall J et al. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder. Neuropsychopharmacology 2012; 37: 2720-2729.
45. Bergen SE, O'Dushlaine CT, Ripke S, Lee PH, Ruderfer DM, Akterin S et al. Genomewide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry 2012; 17: 880-886.
46. Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G et al. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat 2012; 33: 254-263.
47. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 2010; 189: 127-141.
48. Silber J, Lim D, Petritsch C, Persson A, Maunakea A, Yu M et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
49. Smrt RD, Szulwach KE, Pfeiffer RL, Li X, Guo W, Pathania M et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb- 1. Stem Cells 2010; 28: 1060-1070.
50. Green M, Cairns M, Wu J, Dragovic M, Jablensky A, Tooney P et al. Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia. Mol Psychiatry 2012; 18: 774-780.
51. Yin J, Lin J, Luo X, Chen Y, Li Z, Ma G et al. miR-137: A New Player in Schizophrenia. Int J Mol Sci 2014; 15: 3262-3271.
52. Guella I, Sequeira A, Rollins B, Morgan L, Torri F, van Erp TG et al. Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res 2013; 47: 1215-1221.
53. Cummings E, Donohoe G, Hargreaves A, Moore S, Fahey C, Dinan TG et al. Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137. Neurosci Lett 2013; 532: 33-38.
54. Kwon E, Wang W, Tsai LH. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol Psychiatry 2011; 18: 11-12.
55. Kim AH, Parker EK, Williamson V, McMichael GO, Fanous AH, Vladimirov VI. Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. Schizophr Res 2012; 141: 60-64.
56. Egawa J, Nunokawa A, Shibuya M, Watanabe Y, Kaneko N, Igeta H et al. Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population. Psychiatry Clin Neurosci 2013; 67: 277-279.
57. Bemis LT, Chen R, Amato CM, Classen EH, Robinson SE, Coffey DG et al. MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines. Cancer Res 2008; 68: 1362-1368.
58. Althoff K, Beckers A, Odersky A, Mestdagh P, Koster J, Bray IM et al. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A. Int J Cancer 2013; 133: 1064-1073.
59. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, Yu M et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 2008; 6: 14.
60. Geekiyanage H, Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid beta, novel targets in sporadic Alzheimer's disease. J Neurosci 2011; 31: 14820-14830.
61. Geekiyanage H, Jicha GA, Nelson PT, Chan C. Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease. Exp Neurol 2011; 235: 491-496.
62. Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, Rahme R et al. A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 2012; 13: 677.
63. Wright C, Turner J, Calhoun V, Perrone-Bizzozero N. Potential impact of miR-137 and its targets in schizophrenia. Front Genet 2013; 4: 58.
64. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
65. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
66. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
67. Lips ES, Cornelisse LN, Toonen RF, Min JL, Hultman CM, International Schizophrenia Consortium et al. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol Psychiatry 2012; 17: 996-1006.
68. Jia P, Sun J, Guo A, Zhao Z. SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry 2010; 15: 453-462.
69. Jensen L, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009; 37: 6.
70. Takeichi M. The cadherin superfamily in neuronal connections and interactions. Nat Rev Neurosci 2007; 8: 11-20.
71. Junghans D, Heidenreich M, Hack I, Taylor V, Frotscher M, Kemler R. Postsynaptic and differential localization to neuronal subtypes of protocadherin beta16 in the mammalian central nervous system. Eur J Neurosci 2008; 27: 559-571.
72. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z. Candidate genes for schizophrenia: a survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1173-1181.
73. Shao L, Vawter MP. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry 2008; 64: 89-97.
74. Myles-Worsley M, Tiobech J, Browning SR, Korn J, Goodman S, Gentile K et al. Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family. Am J Med Genet B Neuropsychiatr Genet 2013; 162B: 87-95.
75. McCullumsmith RE, Meador-Woodruff JH. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002; 26: 368-375.
76. Lang UE, Puls I, Muller DJ, Strutz-Seebohm N, Gallinat J. Molecular mechanisms of schizophrenia. Cell Physiol Biochem 2007; 20: 687-702.
77. Murphy GG, Fedorov NB, Giese KP, Ohno M, Friedman E, Chen R et al. Increased neuronal excitability, synaptic plasticity, and learning in aged Kvbeta1.1 knockout mice. Curr Biol 2004; 14: 1907-1915.
78. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF, Stanley Neuropathology Consortium. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004; 9: 609-620, 544.
79. Drew CJ, Kyd RJ, Morton AJ. Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normal. Hum Mol Genet 2007; 16: 2288-2305.
80. Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I et al. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat Genet 2010; 42: 1021-1026.
81. Xia J, Zhang W. A meta-analysis revealed insights into the sources, conservation and impact of microRNA 5'-isoforms in four model species. Nucleic Acids Res 2014; 42: 1427-1441.